1 / 26

HEALTH-PROT

HEALTH-PROT. Dr. Urszula Bialek-Wyrzykowska Coordinator International Institute of Molecular and Cell Biology in Warsaw, Poland Granada, 16 March 2010 www.iimcb.gov.pl. Who are we?.

spike
Télécharger la présentation

HEALTH-PROT

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HEALTH-PROT Dr. Urszula Bialek-Wyrzykowska Coordinator International Institute of Molecular and Cell Biology in Warsaw, Poland Granada, 16 March 2010 www.iimcb.gov.pl

  2. Who are we? • IIMCB was created in 1999 based on an agreement between UNESCO and Republic of Poland and on Parliamentary Bills • One of the best Polish research institutes focused on studies of proteins at various levels • Unique in Polish science principles of organization based on the best international standards

  3. What is unique in our organization? • Group leader selection procedure • international competition • PhD and significant publication record • ability to raise extramural funding • Regular evaluation of group leaders • All positions filled through competition procedure • Contract employment for scientific staff • Professional international cooperation unit • International Advisory Board

  4. International Advisory Board (term 2010-2014) Francisco E. Baralle,Director, International Centre, Trieste, Italy Nicolaus Blin, University of Tuebingen, Germany Ineke Braakman, Utrecht University, The Netherlands Ivan Dikic, Goethe University Medical School, Frankfurt, Germany Robert P. Erickson,University ofArizona, USA Witold Filipowicz, Institute for Biomedical Research, Basel, Switzerland Klaus Hahlbrock,Laureate of Humboldt Honorary Res., Germany Wieland Huttner, Director, MPI-CBG, Dresden, Germany Leszek Kaczmarek, Nencki Institute, PAN, Warsaw, Poland Oleg A. Krishtal,Director, Bogomoletz Institute of Physiology, Kiev, Ukraine Jacques Mallet, Hospital de la Pitie-Salpetriere, Paris, France Maciej J. Nalecz, Director, UNESCO, Paris, France Didier Picard, University of Geneva, Switzerland Helen Saibil, Institute for Structural and Molecular Biology, London, UK J. Gregor Sutcliffe, The Scripps Research Institute, California, USA Adam Szewczyk, Nencki Institute of Experimantal Biology, Warsaw, Poland Anna Tramontano, University of Rome, Italy Alexander Wlodawer, National Cancer Institute at Frederick, USA

  5. International sources of funding • EC Framework Programmes • Structural Funds • Max Planck Society • Wellcome Trust • Polish Norwegian Research Fund • Howard Hughes Medical Institute • National Institutes of Health • EMBO

  6. Participation in Framework Programmes FP51 mln EUR Centre of Excellence350 000 EUR ANTISTAPH 238 382 EUR Cell Chip–coordination 231 703 EUR REFLAX 149 000 EUR Chaperones 64 776 EUR CEEBT 23 430 EUR CF-Network9 600 EUR FP62.3 mln EUR MEMPROT - TOK 626 800 EUR PROMEMORIA - IP 478 000 EUR ENDOTRACK - IP 428 400 EUR DNA Enzymes -ITN 254 452 EUR EURASNET - NoE 120 000 EUR PLASTOMICS–STREP164 160 EUR APOPIS – IP161 200 EUR VOLVOX - SSA38 534 EUR EUROGENTEST- NoE 30 000 EUR FP7 1.5 mln EUR HEALTH-PROT - CSA 954 100 EURNEURO.GSK3 – IP 280 840 EUR SBMPs - ITN 263 284 EUR

  7. Milestones of IIMCB development Centre of Excellence in Molecular Bio-Medicine FP5 2003-2006 EC contribution 350 000 EUR Proteins in Health and Disease FP7 2009-2012 EC contribution 954 100 EUR

  8. Evaluation of the proposal 20072008 Scientific and/ortechnological excellence 5/55/5 Quality and efficiency of implementation & management 2.5/5 4.5/5 Potential impact through the development /dissemination and use of project results 5/5 5/5

  9. Objectives • To become a top protein studies centre in the region • To create the place for experienced researchers to conduct research at the highest level • To reach an ultimate critical mass by completing the organisation of IIMCB’s structure • To become more innovative towards applications in medicine and biotechnology • To popularize science and raise social awarness of the benefits of modern biology

  10. Partnering organizations • University of Cardiff, Great Britain • University of Edinburgh, Great Britain • Institute of Biotechnology, Vilnius, Lithuania • University of Bologna, Italy • Erasmus Medical Center, Rotterdam, The Netherlands • Ludwig-Maximilians-University of Munich, Germany • University of Freiburg, Germany • The Norwegian Radium Hospital, Oslo, Norway • Louis Pasteur University, CNRS, Strasbourg, France

  11. Partnering organizations 08/09/2014 08/09/2014

  12. Increasing scientific expertise through twinning 61/9 IIMCB staff visiting Twinning Partners 59/7 scientists from Twinning Partners visiting IIMCB Deliverables: 16 papers in internationally recognized journals

  13. Expanding research capacity Employment of 9/7 experienced researchers 2-year contracts Open international competition Deliverables: Seven to twelve applications for grants, including applications to FP7

  14. Organization of scientific events 9/4 scientific events organized in cooperation with Twinning Partners „Biology of cancer “, 12-13.06.2010, Warsaw, 30 participants „Calcium and diseases”, a session within the ECS meeting 6-9.09.2010, Warsaw, 300 participants Deliverables: Written reports

  15. Participation of Centre’s staff in international events 25/5 international events Active participation (oral presentations or posters) of 52/12 researchers Deliverables: Reports on the participation in the events

  16. Promotional activities and dissemination of knowledge • May 2009: kick-off meeting attendedby representatives • of Ministry of Science and Higher Education, National • Contact Point, Polish Academy of Sciences, twinning • partners and International Advisory Board members • June 2009: project website http://www.iimcb.gov.pl/hp • October 2009: IIMCB’s Centre for Innovative Bioscience • Education promoted the project at National Science • Learning Centre, University of York, UK • March 2010: open day for talented young people • A poster describing the project presented during various • international and domestic events

  17. Management EC project officer Camelia Dogaru Director Jacek Kuznicki Project Manager Ula Wyrzykowska WP1 Leader Michal WittWP2 Leader Jacek KuznickiWP3 Leader Agnieszka ZiemkaWP4 Leader Agnieszka ZiemkaWP5 Leader Magda PowierżaWP6 Leader Dorota Libiszowska

  18. Budget by workpackage EC + national funds Twinning Research capacity

  19. Budget by cost type EC versus national funds

  20. Impact at national level • Upgraded level of research of Polish collaborators • Higher quality of academic education (undergraduate and PhD students) • Introduction of good standards of research organization as exemplified by the success of IIMCB • Positive influence on reshaping science policy in Poland • Increased social awareness of research contribution to sustainable development of the country

  21. Impact at European level • IIMCB researchers will become equal partners to their European peers • Better integration in the ERA: increased capability to enter scientific consortia applying for FP funding • Incentive for novel initiatives driven by technology transfer • Participation in reshaping of European science policy

  22. IIMCB without REGPOT • Imbalance between number of post-doctoral researchers and PhD students not corrected • Full potential of research groups not used • Limited cooperation with European partners • Low level of participation in FP7 and ERA • Reduced pace of IIMCB development towards research excellence at European level

  23. A better REGPOT? • New measure: founding of new laboratories led by outstanding researchers from more developed European regions • Agreement between PAN (Poland) and MPG (Germany) • Laboratory of Structural Biology MPG-PAN at IIMCB • Laboratory of Cell Cortex Mechanics MPG-PAN at MPI-CBG • Higher budget to include more beneficiaries

  24. Annual budgets in EURO HEALTH-PROT CEMBM

  25. Contact International Institute of Molecular and Cell Biology(IIMCB) 4 Ks. Trojdena St  02-109 Warsaw, Poland tel.: +48(22)668 52 20 fax: +48(22)668 52 88 e-mail: secretariat@iimcb.gov.pl www.iimcb.gov.pl

More Related